Bioinformatics: Technologies and Global Markets

  • ID: 4659347
  • Report
  • Region: Global
  • 219 Pages
  • BCC Research
15 % OFF
until Dec 31st 2018
1 of 6

FEATURED COMPANIES

  • 3rd Millennium, Inc.
  • Dassault Systemes Biovia
  • Genomatix Software Gmbh
  • Macvector, Inc.
  • Ocimum Biosolutions Ltd.
  • Real Time Genomics, Inc.
  • MORE

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industry to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

The Report Includes:

  • 28 data tables and 72 additional tables
  • An overview of the global market for bioinformatic technologies and their applications
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of the goal of bioinformatics and their role in systems biology
  • Insight into the application of bioinformatics on drug development, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • Detailed profiles of major companies in the market, including 3rd Millennium, Inc., Biomatters Ltd., Compugen Ltd., DNASTAR, Inc., and Illumina, Inc.

Membership Price:

Contact us for membership pricing.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 3rd Millennium, Inc.
  • Dassault Systemes Biovia
  • Genomatix Software Gmbh
  • Macvector, Inc.
  • Ocimum Biosolutions Ltd.
  • Real Time Genomics, Inc.
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Global Bioinformatics Market: Overview

  • Goal of Bioinformatics
  • Biological Data Sources
  • Bioinformatics in Systems Biology
  • Precision Medicine
  • Bioinformatics in Drug Development
  • Cheminformatics
  • Next-Generation Sequencing
  • Metagenomics
  • Database Management Systems
  • Market Trends
  • Precision Medicine and Biomarker Identification
  • Cloud-Based Solutions
  • Shift Toward Value-Based Care
  • Market Challenges
  • Data Integration
  • Data Reliability and Standardization
  • End-to-End Workflows
  • Current Market
  • Market by Region
  • Market by Category
  • Public Funding
  • Private Funding
  • Market by Application

Chapter 4 Bioinformatics: Data Generation and Data Management

  • Information Overload
  • Data Volume
  • Data Variety
  • Data Velocity
  • Data Veracity
  • Software Scalability and Validity
  • Technologies Behind Big Data Generation
  • Genomics
  • Sequencing Genomics
  • Metagenomics
  • Exponential Growth in NGS Software Tools
  • Functional Genomics
  • Functional Genomics in Drug Discovery
  • CRISPR Cas9 System
  • Proteomic Advances
  • Qualitative Proteomics
  • Quantitative Proteomics
  • Structural Proteomics
  • Advances in MS-Based Proteomics Technology for Exploring Triple Negative Breast Cancer
  • Investments in Structural Genomics and Open Science
  • Interaction Proteomics
  • Application in Drug Discovery
  • Bottom-Up Vs. Top-Down Proteomics
  • Emergence of Glycomics
  • Human Proteome Organization and Human Proteome Project Initiatives
  • Transcriptomic Advances
  • RNA Sequencing
  • Co-Expression and Single-Cell RNA-Seq
  • Metabolomic Advances
  • Advances in Cheminformatics
  • Emerging Technologies
  • Metagenomic Advances
  • Epigenomic Advances
  • Pharmacogenomic Advances
  • Pharmacogenomics and Precision Medicine
  • Value-Based Decisions
  • Pharmacogenomics and R&D
  • International Serious Adverse Events Consortium
  • Pharmacogenomic Software
  • Toxicogenomic Advances
  • Customized Toxicogenomic Platforms
  • Database Management Services
  • Market Dynamics

Chapter 5 Bioinformatics: Data Analysis and Software

  • Introduction
  • Data Analysis Software
  • Biosimulation Models
  • Market Analysis

Chapter 6 Bioinformatics: Data Processing and Storage

  • Mind the Gap
  • Information Technology Infrastructure
  • High-Performance Computing
  • High-Performance Computer Clusters
  • Cloud Computing
  • Data as a Service
  • Infrastructure as a Service
  • Platform as a Service
  • Software as a Service
  • Security as a Service
  • Cloud Computing Challenges
  • Future of Cloud Computing
  • Market Analysis

Chapter 7 Bioinformatics: Sequencing Services and Platforms

  • Market Analysis
  • Comparative Analysis Across Market Segments 2016 and 2022
  • Sequencing Services
  • Sequencing Platforms
  • Sequence Analysis Platforms
  • Sequence Alignment Platforms
  • Sequence Manipulation Platforms

Chapter 8 Bioinformatics: Sequencing Applications

  • Market Analysis
  • Agrigenomics
  • Clinical and Medical
  • Genealogy
  • Other Fields

Chapter 9 Bioinformatic Applications in Pharmaceutical R&D

  • Introduction
  • Drug Discovery and Development Process
  • Target Identification
  • Target Validation
  • Lead Identification
  • Lead Optimization
  • Clinical Research: Drug Development
  • Preclinical Experiments
  • Laboratory Information Management Systems
  • Electronic Laboratory Notebooks
  • Investigational New Drug Applications
  • Clinical Trials
  • Bioinformatics in Clinical Trial Design and Data Collation
  • New Drug Application
  • NDA Approval
  • Post-Launch Ongoing Studies and Phase IV Clinical Trials
  • Electronic Health Records
  • Mobile Health Technologies
  • Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
  • Conclusions

Chapter 10 Market Trends and Analysis

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Switzerland
  • Asia-Pacific
  • India
  • China
  • Conclusions

Chapter 11 Company Profiles

  • 3rd Millennium, Inc.
  • Biomatters Ltd.
  • Compugen Ltd.
  • Dassault Systemes Biovia
  • Dnastar, Inc.
  • Genedata Ag
  • Geneva Bioformatics (Genebio) Sa
  • Genologics Lifesciences Software, Inc.
  • Genomatix Software Gmbh
  • GNS Healthcare, Inc.
  • GVK Biosciences Private Ltd.
  • Inte:Ligand Software Entwicklungs Und Consulting Gmbh
  • Illumina, Inc.
  • Macvector, Inc.
  • Molecular Connections Private Ltd.
  • Molecular Networks Gmbh
  • Nonlinear Dynamics Ltd.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer Informatics, Inc.
  • Personalis, Inc.
  • Qlucore Ab
  • Real Time Genomics, Inc.
  • Smartgene Services Sarl
  • Strand Life Sciences
  • Syngene International

List of Tables
Summary Table: Global Bioinformatics Market, by Region, Through 2022
Table 1: PDB Data Distribution, by Experimental Method and Molecular Type
Table 2: RefSeq Accession Growth, 2016 and 2018
Table 3: Recommendations for NGS Bioinformatics Tools
Table 4: Leading Institutional Developers of Bioinformatics Tools, 2017
Table 5: Bioinformatics Tools Used for Metagenomics Analysis
Table 6: DBMS Platforms in Bioinformatics
Table 7: FDA and EMA Drug Approvals, 2012-2016
Table 8: Global Bioinformatics Market, by Region, Through 2022
Table 9: Public Funding Programs, by Country, 2012-2018
Table 10: Global Bioinformatics Market, by Category, Through 2022
Table 11: Global Bioinformatics Market, by Application, Through 2022
Table 12: Cloud-Based Bioinformatics Tools
Table 13: Commercially Available Metabolomic Software
Table 14: Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
Table 15: Cheminformatics Software Solutions for Drug R&D
Table 16: Bioinformatic Tools for Metagenomic Studies
Table 17: Pharmacogenomic Biomarkers in Drug Labeling
Table 18: Bioinformatics Tools and Databases Used in Pharmacogenomics
Table 19: Bioinformatic Tools for Pharmacogenomic Studies
Table 20: Bioinformatic Tools for Pharmacogenomic Software
Table 21: Toxicogenomic Studies Planned or Ongoing, 2016
Table 22: Archival Databases
Table 23: Curative Databases
Table 24: Commercially Available Databases
Table 25: Biological Databases for Human Research
Table 26: Software for Biological Analysis
Table 27: Open Source Bioinformatics Software
Table 28: NGS Platforms for Clinical Diagnostics
Table 29: Commonly Used Tools for NGS-based DNA Analysis, by Functional Category
Table 30: Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
Table 31: High-performance Computing Architectures: Advantages and Drawbacks
Table 32: Highest Performance Supercomputers, 2018
Table 33: SaaS Products
Table 34: Global Bioinformatics Market, by Sequencing Services and Platforms, Through 2022
Table 35: Sequence Analysis Software
Table 36: Sequence Alignment Platforms
Table 37: Global Bioinformatics Market, by Sequencing Application, Through 2022
Table 38: Sequencing Data Analysis Bioinformatics Software and Tools
Table 39: Bioinformatics-based Clinical and Medical Laboratory Information Management System
Table 40: Number of Medicines Developed Globally, 2017
Table 41: Bioinformatics Databases
Table 42: Leading Drug Target Databases
Table 43: Computer Simulation Platforms
Table 44: Leading LIMS Providers
Table 45: Key Suppliers of ELNs
Table 46: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 47: Drug R&D Process Overview
Table 48: Leading EHR Providers, 2018
Table 49: Medical Applications for Healthcare Professionals
Table 50: Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2017
Table 51: North American Bioinformatics Market, by RegionCountry, Through 2022c
Table 52: Leading Bioinformatics Companies in the U.S.
Table 53: Venture Capital Companies Most Active in the Biotech Sector, 2015
Table 54: U.S. Bioinformatics Market, by Application, Through 2022
Table 55: U.S. Bioinformatics Market, by Category, Through 2022
Table 56: Canadian Bioinformatics Market, by Category, Through 2022
Table 57: Leading Canadian Bioinformatics Companies
Table 58: Canadian Bioinformatic Market, by Application, Through 2022
Table 59: European Bioinformatics Market, by Country, Through 2022
Table 60: Leading European Bioinformatics Companies
Table 61: U.K. Bioinformatics Market, by Category, Through 2022
Table 62: U.K. Bioinformatics Market, by Application, Through 2022
Table 63: Germany Bioinformatics Market, by Category, Through 2022
Table 64: Germany Bioinformatics Market, by Application, Through 2022
Table 65: Switzerland Bioinformatics Market, by Category, Through 2022
Table 66: Switzerland Bioinformatics Market, by Application, Through 2022
Table 67: Rest of European Bioinformatics Market, by Application, Through 2022
Table 68: Rest of Europeon Bioinformatics Market, by Category, Through 2022
Table 69: Asia-Pacific Bioinformatics Market, by Country, Through 2022
Table 70: Indian Bioinformatics Market, by Category, Through 2022
Table 71: Leading Indian Bioinformatics Companies
Table 72: Indian Bioinformatics Market, by Application, Through 2022
Table 73: China Bioinformatics Market, by Category, Through 2022
Table 74: China Bioinformatics Market, by Application, Through 2022
Table 75: Rest of Asia-Pacific Bioinformatics Market, by Application, Through 2022
Table 76: Rest of Asia-Pacific Bioinformatics Market, by Category, Through 2022
Table 77: Biomatters Ltd.: Product Portfolio
Table 78: Compugen Ltd.: Product Portfolio
Table 79: Dassault Systemes Biovia: Product Portfolio
Table 80: Dnastar, Inc.: Product Portfolio
Table 81: Dnastar, Inc.: Recent Developments, 2016
Table 82: Genedata AG: Product Portfolio
Table 83: Genedata AG: Recent Developments, 2017
Table 84: Geneva Bioformatics (Genebio) SA: Product Portfolio
Table 85: Genologics Lifesciences Software, Inc.: Product Portfolio
Table 86: Genomatix Software GMBH: Product Portfolio
Table 87: GNS Healthcare, Inc.: Product Portfolio
Table 88: GNS Healthcare, Inc.: Recent Developments, 2015-2017
Table 89: GVK Biosciences Private Ltd.: Product Portfolio
Table 90: GVK Biosciences Private Ltd: Recent Developments, 2017
Table 91: Inte:Ligand Software Entwicklungs Und Consulting Gmbh: Product Portfolio
Table 92: Illumina, Inc.: Product Portfolio
Table 93: Illumina, Inc.: Recent Developments, 2016-2017
Table 94: Macvector, Inc.: Product Portfolio
Table 95: Molecular Connections Private Ltd.: Product Portfolio
Table 96: Molecular Networks Gmbh: Product Portfolio
Table 97: Nonlinear Dynamics Ltd.: Product Portfolio
Table 98: Ocimum Biosolutions Ltd.: Product Portfolio
Table 99: Perkin Elmer Informatics, Inc.: Product Portfolio
Table 100: Personalis, Inc.: Product Portfolio
Table 101: Qlucore AB: Product Portfolio
Table 102: Qlucore AB: Recent Developments, 2018
Table 103: Real Time Genomics, Inc.: Product Portfolio
Table 104: Real Time Genomics, Inc.: Recent Developments, 2016
Table 105: Smartgene Services SARL: Product Portfolio
Table 106: Strand Life Sciences: Product Portfolio
Table 107: Strand Life Sciences: Recent Developments, 2017 and 2018
Table 108: Syngene International: Product Portfolio
Table 109: Syngene International: Recent Developments, 2016-2018

List of Figures
Summary Figure: Global Bioinformatics Market, by Region, 2016-2022
Figure 1: PDB Data Distribution, by Experimental Method and Molecular Type
Figure 2: RefSeq Accession Growth, 2016 and 2018
Figure 3: Relationship of Bioinformatics with Omic Technologies
Figure 4: Schematic Representation of Biology Systems and Translational Bioinformatics
Figure 5: Principles of Precision Medicine
Figure 6: Applications of Bioinformatics on Drug Development
Figure 7: Collaboration within the Bioinformatics Arena, by Country, 2016
Figure 8: Drug Approvals, by FDA’s CDER, 2008-2018
Figure 9: Four Dimensions of Big Data
Figure 10: Software Scalability of Big Data Bioinformatics
Figure 11: Software Validation of Big Data Bioinformatics
Figure 12: Top-Down Proteomic Approach
Figure 13: European Bioinformatics Institute Software Solutions
Figure 14: Evolution of Information Technology Infrastructure
Figure 15: Schematic Representation of Cloud Computing Services
Figure 16: Global Bioinformatics Market Share, by Sequencing Services and Platforms, 2016 and 2022
Figure 17: Global Bioinformatics Market, by Sequencing Services, 2016-2022
Figure 18: Global Bioinformatics Market, by Sequencing Platform, 2016-2022
Figure 19: Clinical Bioinformatics for Patients for Precision Health
Figure 20: Number of Drugs Developed for Diseases, 2017
Figure 21: Classical and Digital Forensics with Respect to Bioinformatics
Figure 22: Drug Development Process
Figure 23: Phases in the Drug Discovery and Development Process
Figure 24: Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines, 2017
Figure 25: Steps in Drug Discovery
Figure 26: Information Systems within the Laboratory Architecture
Figure 27: Application of Bioinformatics in Clinical Trials
Figure 28: Key Areas of Research Utilizing Bioinformatics

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 3rd Millennium, Inc.
  • Dassault Systemes Biovia
  • Genomatix Software Gmbh
  • Macvector, Inc.
  • Ocimum Biosolutions Ltd.
  • Real Time Genomics, Inc.
  • MORE

Bioinformatics is the science of managing, analyzing, storing and merging biological data using advanced computing techniques. It requires a multidisciplinary approach and draws information from different disciplines to make vast, diverse and complex life science data more understandable and useful. The rapid growth in raw data generation and advances in IT software and infrastructure have enabled researchers to integrate disparate data sets in order to decipher complex biological processes and develop predictive models of disease, for the purposes of identifying and validating novel biomarkers and developing precision medicines.

The global bioinformatics market attracts considerable funding from governments, and it is driven by applications across many sectors, including biotechnology, pharmaceutical agriculture, food safety, chemical and manufacturing.

Reasons for Doing This Study

Since scientists unraveled the blueprint of the human genome more than 10 years ago, they have been exploring new ways to utilize “omic” data to understand more complex diseases. Researchers are eager to analyze as many different types of data as possible to gain a better understanding of that which is happening at the cellular and molecular levels. Service providers have developed new analytical tools and IT infrastructures to enable scientists to interrogate complex data sources, and quickly and efficiently disseminate information for better decision-making to achieve this goal.

More recently, improvements in cloud computing capabilities, advances in data analysis software services and the growth of NGS technologies have helped to expand the evaluation of available datasets, allowing researchers to build systems biology models of various diseases.

Note: Product cover images may vary from those shown
5 of 6
  • 3rd Millennium, Inc.
  • Biomatters Ltd.
  • Compugen Ltd.
  • Dassault Systemes Biovia
  • Dnastar, Inc.
  • Genedata Ag
  • Geneva Bioformatics (Genebio) Sa
  • Genologics Lifesciences Software, Inc.
  • Genomatix Software Gmbh
  • GNS Healthcare, Inc.
  • GVK Biosciences Private Ltd.
  • Illumina, Inc.
  • Inte:Ligand Software Entwicklungs Und Consulting Gmbh
  • Macvector, Inc.
  • Molecular Connections Private Ltd.
  • Molecular Networks Gmbh
  • Nonlinear Dynamics Ltd.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer Informatics, Inc.
  • Personalis, Inc.
  • Qlucore Ab
  • Real Time Genomics, Inc.
  • Smartgene Services Sarl
  • Strand Life Sciences
  • Syngene International
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll